ABP-102

N/A

Report date: 2026/03/19 17:18:10

Base Information

Drug NameABP-102
Drug Alias NameABP-102ABP-102 (Abpro/Celltrion)CT-P72
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 modulatorsT cell surface glycoprotein CD3 modulators
TargetsReceptor protein-tyrosine kinase erbB-2T cell surface glycoprotein CD3
Therapy Area/IndicationsBreast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesAbpro Corp
China Registration ClassN/A

Develop Information

Active CompaniesCelltrion IncAbpro Corp
Inactive CompaniesN/A
Active IndicationsBreast NeoplasmsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A